Amarantus Bioscience Holdings Inc. (OTCMKTS:AMBS – Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 15th, there was short interest totaling 73,532 shares. Based on an average trading volume of 37,191 shares, the days-to-cover ratio is presently 2.0 days.
Amarantus Bioscience Price Performance
Amarantus Bioscience has a 1-year low of $0.00 and a 1-year high of $0.01.
Amarantus Bioscience Company Profile
Amarantus Bioscience, Inc is a biotechnology company that historically focused on developing therapeutics and diagnostics for neurological and other serious diseases. Its research programs centered on mesencephalic astrocyte-derived neurotrophic factor (MANF), a naturally occurring protein investigated for potential applications in disorders involving nerve-cell damage.
The company also pursued the development of NuroPro, a blood-based diagnostic platform intended to identify biomarkers associated with neurodegenerative diseases, including Parkinson’s disease.
Further Reading
- Five stocks we like better than Amarantus Bioscience
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Amarantus Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amarantus Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
